Siemens takes control of "lab-on-a-chip" device
This article was originally published in Clinica
Executive Summary
In what could mark the company's entry into the near-patient testing market, Siemens Medical Solutions has taken developmental control of a biochip technology, or, so-called "lab-on-a-chip" device, called Quicklab. The company, more traditionally associated with providing for the medical imaging industry, said it aimed to take the product to market readiness.